Entry |
|
Name |
Parnaparin sodium (JP18); Lowhepa (TN) |
Class |
Blood modifier agent
DG01950 Antithrombotic agent
DG01709 Heparin anticoagulant
|
Remark |
Therapeutic category: | 3334 |
Product (DG00150): | D02112<JP/US> D04427<JP> D03674<JP/US> D04977<JP> D03353<JP/US> |
|
Efficacy |
Anticoagulant, Antithrombin III activator |
Comment |
Low molecular weight heparin (LMWH)
|
Target |
|
Pathway |
hsa04610 | Complement and coagulation cascades |
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AB Heparin group
B01AB07 Parnaparin
D04977 Parnaparin sodium (JP18) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
33 Blood and body fluid agents
333 Anticoagulants
3334 Heparins
D04977 Parnaparin sodium (JP18)
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01709 Heparin anticoagulant
DG00150 Heparin
D04977 Parnaparin sodium
Target-based classification of drugs [BR:br08310]
Not elsewhere classified
Organismal systems
Complement and coagulation
SERPINC1 (AT3)
D04977 Parnaparin sodium (JP18) <JP>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D04977 Parnaparin sodium
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01709 Heparin anticoagulant
DG00150 Heparin
|
Other DBs |
|
LinkDB |
|